160 related articles for article (PubMed ID: 21843608)
41. Enhanced oral bioavailability of poorly absorbed drugs. I. Screening of absorption carrier for the ceftriaxone complex.
Cho SW; Lee JS; Choi SH
J Pharm Sci; 2004 Mar; 93(3):612-20. PubMed ID: 14762900
[TBL] [Abstract][Full Text] [Related]
42. Mechanism of gastrointestinal absorption of glycyrrhizin in rats.
Wang Z; Kurosaki Y; Nakayama T; Kimura T
Biol Pharm Bull; 1994 Oct; 17(10):1399-403. PubMed ID: 7874064
[TBL] [Abstract][Full Text] [Related]
43. Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration.
Bulmer AC; Coombes JS; Blanchfield JT; Toth I; Fassett RG; Taylor SM
Br J Pharmacol; 2011 Dec; 164(7):1857-70. PubMed ID: 21486273
[TBL] [Abstract][Full Text] [Related]
44. [Effects of absorption enhancers on intestinal absorption of lumbrokinase].
Li YH; Zhang M; Wang JC; Zhang S; Liu JR; Zhang Q
Yao Xue Xue Bao; 2006 Oct; 41(10):939-44. PubMed ID: 17184110
[TBL] [Abstract][Full Text] [Related]
45. In vivo analysis of supersaturation/precipitation/absorption behavior after oral administration of pioglitazone hydrochloride salt; determinant site of oral absorption.
Tanaka Y; Sugihara M; Kawakami A; Imai S; Itou T; Murase H; Saiki K; Kasaoka S; Yoshikawa H
Eur J Pharm Sci; 2017 Aug; 106():431-438. PubMed ID: 28603033
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of factors affecting gastrointestinal absorption of a novel anticoagulant FX-93 for development of oral formulation.
Takemura S; Kondo H; Suzumura K; Ogawara K; Watanabe S; Sako K; Higaki K
J Pharm Sci; 2012 Jun; 101(6):2134-42. PubMed ID: 22422596
[TBL] [Abstract][Full Text] [Related]
47. In vitro assessment of competitive and time-dependent inhibition of the nevirapine metabolism by nortriptyline in rats.
Usach I; Ferrer JM; Peris JE
Biochem Pharmacol; 2018 Aug; 154():1-9. PubMed ID: 29674001
[TBL] [Abstract][Full Text] [Related]
48. Oral absorption of anti-aids nucleoside analogues: 3. Regional absorption and in vivo permeability of 2',3'-dideoxyinosine in an intestinal-vascular access port (IVAP) dog model.
Sinko PJ; Sutyak JP; Leesman GD; Hu P; Makhey VD; Yu H; Smith CL
Biopharm Drug Dispos; 1997 Nov; 18(8):697-710. PubMed ID: 9373726
[TBL] [Abstract][Full Text] [Related]
49. Sex-dependent metabolism of nevirapine in rats: impact on plasma levels, pharmacokinetics and interaction with nortriptyline.
Usach I; Compañ P; Peris JE
Int J Antimicrob Agents; 2018 May; 51(5):707-713. PubMed ID: 29309900
[TBL] [Abstract][Full Text] [Related]
50. [Pharmacokinetic study on absorption of stachyose].
Zheng N; Ruan J; Zhang Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Jun; 20(6):444-6. PubMed ID: 11789231
[TBL] [Abstract][Full Text] [Related]
51. A self-assembled nanodelivery system enhances the oral bioavailability of daidzein: in vitro characteristics and in vivo performance.
Zhang Z; Huang Y; Gao F; Gao Z; Bu H; Gu W; Li Y
Nanomedicine (Lond); 2011 Oct; 6(8):1365-79. PubMed ID: 22026378
[TBL] [Abstract][Full Text] [Related]
52. Intestinal absorption and biliary elimination of glycyrrhizic acid diethyl ester in rats.
Koga K; Kawamura M; Iwase H; Yoshikawa N
Drug Des Devel Ther; 2013; 7():1235-43. PubMed ID: 24174868
[TBL] [Abstract][Full Text] [Related]
53. Bile flow in the rat after enteral administration of bile salts.
Nightingale CH; Gibaldi M
Am J Dig Dis; 1969 Aug; 14(8):545-56. PubMed ID: 5805230
[No Abstract] [Full Text] [Related]
54. [Absorption of extractive Polygonum orientale in rat everted gut sacs].
Liu Y; Tang L; Cao X; Zheng L; Wang AM; Huang Y
Zhongguo Zhong Yao Za Zhi; 2014 Jun; 39(11):2121-5. PubMed ID: 25272855
[TBL] [Abstract][Full Text] [Related]
55. Study of the absorption site of cimetidine.
Kaneniwa N; Funaki T; Furuta S; Watari N
J Pharmacobiodyn; 1986 Mar; 9(3):321-6. PubMed ID: 3723322
[TBL] [Abstract][Full Text] [Related]
56. Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study.
Niu M; Tan Y; Guan P; Hovgaard L; Lu Y; Qi J; Lian R; Li X; Wu W
Int J Pharm; 2014 Jan; 460(1-2):119-30. PubMed ID: 24275447
[TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetics of DA-7867, a new oxazolidinone, after intravenous or oral administration to rats: intestinal first-pass effect.
Bae SK; Chung WS; Kim EJ; Rhee JK; Kwon JW; Kim WB; Lee MG
Antimicrob Agents Chemother; 2004 Feb; 48(2):659-62. PubMed ID: 14742232
[TBL] [Abstract][Full Text] [Related]
58. Increased intestinal absorption of mizoribine, an immunosuppressive agent, in cholestatic rats.
Mori N; Yokooji T; Kamio Y; Murakami T
Pharmazie; 2010 Jul; 65(7):457-60. PubMed ID: 20662310
[TBL] [Abstract][Full Text] [Related]
59. Toxicological assessment of liquorice: biliary excretion in rats.
Cantelli-Forti G; Raggi MA; Bugamelli F; Maffei F; Villari A; Trieff NM
Pharmacol Res; 1997 May; 35(5):463-70. PubMed ID: 9299212
[TBL] [Abstract][Full Text] [Related]
60. Absorption of [7,8-14C]rac-a-lipoic acid from in situ ligated segments of the gastrointestinal tract of the rat.
Peter G; Borbe HO
Arzneimittelforschung; 1995 Mar; 45(3):293-9. PubMed ID: 7741788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
